Press Releases

Biocartis and Ophiomics to Collaborate on Liver Cancer Test

Large UK Study Shows Rapid EGFR Testing with Idylla Alongside NGS Has Potential to Enhance Lung Cancer Patient Health Outcomes

Biocartis’ Idylla™ SARS-CoV-2 testing Successfully Detects Omicron Variant

SeptiCyte® RAPID Receives 510(k) clearance by US FDA

New Study Demonstrates Idylla™ EGFR Mutation Test (CE-IVD) Shortens Time to Patient Management Decisions for Patients with Non-Small Cell Lung Cancer

Biocartis Launches Idylla™ SARS-CoV-2/Flu/RSV Panel

Biocartis Receives EUR 1.4m Grant to Support Development of New Idylla™ Technology to Unlock Potential in Molecular Surveillance

Biocartis Announces New Collaboration with AstraZeneca to Expand Availability of Idylla™ EGFR Biomarker Testing Among Patients with Lung Cancer

Biocartis and SkylineDx Sign Collaboration to Develop the Merlin Assay, a Test Predicting Risk for Nodal Metastasis in Melanoma, on Idylla™

Biocartis Launches Idylla™ GeneFusion Assay as Rapid Lab Workflow Solution for Gene Fusion Testing